{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:52:19Z","timestamp":1793674339839,"version":"4.5.1"},"reference-count":27,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Michael J. Fox Foundation","award":["MJFF-010312"],"award-info":[{"award-number":["MJFF-010312"]}]},{"name":"Michael J. Fox Foundation","award":["MJFF-019055"],"award-info":[{"award-number":["MJFF-019055"]}]},{"name":"Michael J. Fox Foundation","award":["MJFF019169"],"award-info":[{"award-number":["MJFF019169"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The development of PET tracers for the detection of pathological alpha-synuclein (a-synuclein) has the potential to revolutionize the diagnosis, monitoring, and therapeutic interventions of synucleinopathies, including Parkinson\u2019s disease. The journey toward identifying effective PET imaging agents, however, has faced significant challenges due to the complexity and heterogeneity of the a-synuclein structures. Achieving the goal is further compounded by the low density of the pathological target, necessitating that the tracer exhibits a high binding potential, as well as the co-existence of other protein aggregates, requiring the tracer to be highly specific and selective for a-synuclein. In this perspective article, the challenges regarding developing PET tracers for a-synuclein are explored and summarized, together with the most significant recent advances in the field. These include the approaches used by our laboratories, leading to the publication of the first clinical PET images of a-synuclein pathology in patients with multiple system atrophy (MSA). Building on the current understanding of the different a-synuclein species and findings based on the success of PET tracers in the field of neurodegenerative diseases, future directions are considered also to achieve the imaging of a-synuclein pathology in Parkinson\u2019s patients.<\/jats:p>","DOI":"10.3390\/cells14110834","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:51:04Z","timestamp":1749027064000},"page":"834","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["a-synuclein PET Imaging: From Clinical Utility in Multiple System Atrophy to the Possible Diagnosis of Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Francesca","family":"Capotosti","sequence":"first","affiliation":[{"name":"AC Immune SA, 1015 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The Function of \u03b1-Synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and Molecular Diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A Biological Definition of Neuronal \u03b1-Synuclein Disease: Towards an Integrated Staging System for Research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"H\u00f6glinger, G.U., and Lang, A.E. (2024). SynNeurGe: The Road Ahead for a Biological Definition of Parkinson\u2019s Disease. J. Park. Dis., 1877718X241298194.","DOI":"10.1177\/1877718X241298194"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson s Disease: Clinical Features and Diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.tibtech.2024.01.007","article-title":"\u03b1-Synuclein Seed Amplification Technology for Parkinson\u2019s Disease and Related Synucleinopathies","volume":"42","author":"Soto","year":"2024","journal-title":"Trends Biotechnol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/alz.13735","article-title":"Examining Amyloid Reduction as a Surrogate Endpoint through Latent Class Analysis Using Clinical Trial Data for Dominantly Inherited Alzheimer\u2019s Disease","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/alz.13533","article-title":"Novel Avenues of Tau Research","volume":"20","author":"Sexton","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","article-title":"The \u03b1-Synuclein PET Tracer [18F] ACI-12589 Distinguishes Multiple System Atrophy from Other Neurodegenerative Diseases","volume":"14","author":"Smith","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mehra, S., Gadhe, L., Bera, R., Sawner, A.S., and Maji, S.K. (2021). Structural and Functional Insights into \u03b1-Synuclein Fibril Polymorphism. Biomolecules, 11.","DOI":"10.3390\/biom11101419"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/mds.28984","article-title":"A-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives","volume":"37","author":"Alzghool","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-Synuclein Filaments from Human Brains with Lewy Pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/pri.28125","article-title":"In Vitro Aggregation Assays for the Characterization of \u03b1-Synuclein Prion-like Properties","volume":"8","author":"Narkiewicz","year":"2014","journal-title":"Prion"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acschemneuro.8b00177","article-title":"Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules","volume":"9","author":"Hsieh","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_15","first-page":"1234","article-title":"Neuropathology of Dementia in Patients with Parkinson\u2019s Disease: A Systematic Review of Autopsy Studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy Bodies in Alzheimer\u2019s Disease: A Neuropathological Review of 145 Cases Using \u03b1-Synuclein Immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2967\/jnumed.124.267767","article-title":"Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET\/CT Imager","volume":"65","author":"Li","year":"2024","journal-title":"J. Nucl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/nan.12362","article-title":"Progression of Alpha-synuclein Pathology in Multiple System Atrophy of the Cerebellar Type","volume":"43","author":"Brettschneider","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/mds.20537","article-title":"Grading of Neuropathology in Multiple System Atrophy: Proposal for a Novel Scale","volume":"20","author":"Jellinger","year":"2005","journal-title":"Mov. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/mds.29186","article-title":"High-Contrast Imaging of A-Synuclein Pathologies in Living Patients with Multiple System Atrophy","volume":"37","author":"Matsuoka","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Maurer, A., Bonanno, F., Saw, R.S., Buss, S., Kuebler, L., Ryazanov, S., Leonov, A., Bleher, D., Grotegerd, K., and Pethe, M. (2023). Development and Radiosynthesis of [11C]MODAG-005 for in Vivo Imaging of Alpha-Synuclein Pathology. Nucl. Med. Biol., 126\u2013127.","DOI":"10.1016\/j.nucmedbio.2023.108682"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.neuron.2024.05.006","article-title":"Imaging \u03b1-Synuclein Pathologies in Animal Models and Patients with Parkinson\u2019s and Related Diseases","volume":"112","author":"Endo","year":"2024","journal-title":"Neuron"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00401-024-02801-2","article-title":"Association of in Vivo Retention of [18f] Flortaucipir Pet with Tau Neuropathology in Corresponding Brain Regions","volume":"148","author":"Freiburghaus","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awp282","article-title":"Brain Alpha-Synuclein Accumulation in Multiple System Atrophy, Parkinson\u2019s Disease and Progressive Supranuclear Palsy: A Comparative Investigation","volume":"133","author":"Tong","year":"2010","journal-title":"Brain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal Dominant Parkinson\u2019s Disease Caused by SNCA Duplications","volume":"22","author":"Konno","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_27","unstructured":"(2025, April 11). Finally, PET Tracers for \u03b1-Synuclein Yield Signal in Idiopathic Parkinson\u2019s. Available online: https:\/\/www.alzforum.org\/news\/conference-coverage\/finally-pet-tracers-synuclein-yield-signal-idiopathic-parkinsons."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/11\/834\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:41Z","timestamp":1760032001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/11\/834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cells14110834"],"URL":"https:\/\/doi.org\/10.3390\/cells14110834","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}